Skip to search formSkip to main contentSkip to account menu

phosphatidylinositol 3,4-diphosphate

Known as: phosphatidylinositol 3,4-bisphosphate, 3,4-PIP2, PtdIns(3,4)P2 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2008
Review
2008
The PTEN tumour suppressor is a lipid and protein phosphatase that inhibits phosphoinositide 3-kinase (PI3K)-dependent signalling… 
Highly Cited
1999
Highly Cited
1999
We have tested the binding specificities of the pleckstrin homology (PH) domains of protein kinase B (PKB) and GRP1 (general… 
Highly Cited
1998
Highly Cited
1998
Phosphatidylinositol 3‐kinase (PI3K) mediates a variety of cellular responses by generating PtdIns(3,4)P2 and PtdIns(3,4,5)P3… 
Highly Cited
1998
Highly Cited
1998
The serine-threonine kinase Akt/PKB is activated downstream of phosphatidylinositol 3-kinase in response to several growth factor… 
Highly Cited
1998
Highly Cited
1998
The cellular effects of MCP-1 are mediated primarily by binding to CC chemokine receptor-2. We report here that MCP-1 stimulates… 
Highly Cited
1998
Highly Cited
1998
The aggregation of human platelets is an important physiological hemostatic event contingent upon receptor-dependent activation… 
Highly Cited
1996
Highly Cited
1996
The production, survival, and function of monocytes and macrophages is regulated by the macrophage colony-stimulating factor (M… 
Highly Cited
1985
Highly Cited
1985
A complete separation of myo-inositol 1,4,5-[4,5-(32)P]trisphosphate prepared from human erythrocytes, and myo-[2-3H]inositol 1,3…